Mycenax Biotech Inc
TPEX:4726
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Mycenax Biotech Inc (4726) under the Base Case is TWD per share. Compared with the current market price of 22.45 TWD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Mycenax Biotech Does
Mycenax Biotech, Inc. engages in the research and development, manufacture, and sale of biopharmaceutical products. The company is headquartered in Zhubei, Hsinchu. The company went IPO on 2008-10-30. Its products are derived from mammalian cell culture and microbial fermentation. Its products include TuNEX, LusiNEX, GranNEX and AiNEX. Its products are applied in treatment of brain cancer, psoriasis and renal cell carcinoma, among others.
- Headquarters
- Taiwan TW
- Employees
- 25
- IPO date
- Oct 30, 2008
Revenue & Expenses Breakdown
Mycenax Biotech Inc
Earnings Waterfall
Mycenax Biotech Inc
What is the Intrinsic Value of one Mycenax Biotech Inc stock?
The intrinsic value for Mycenax Biotech Inc (4726) under the Base Case is TWD.
Is Mycenax Biotech Inc stock undervalued or overvalued?
Compared with the current market price of 22.45 TWD, the stock appears .